Posttranslational regulation of augurin, a new secretory tumor suppressor
新型分泌型肿瘤抑制因子 Augurin 的翻译后调控
基本信息
- 批准号:8609081
- 负责人:
- 金额:$ 21.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcylationAddressAdultBiologicalBiological AssayBiological MarkersBiologyBiopsyBrainBrain NeoplasmsCancer cell lineCell AgingCell DeathCell Differentiation processCell LineCell ProliferationCell Proliferation RegulationCellsCleaved cellCorticotropinDataDevelopmentDropsEnhancersEsophagusExhibitsFamilyFutureGenesGenomeGlioblastomaGliomaGoalsGrantGrowthHypermethylationHypothalamic structureIn VitroInorganic SulfatesLinkMalignant NeoplasmsMalignant neoplasm of brainMalignant neoplasm of esophagusMass Spectrum AnalysisMessenger RNAMetabolismMolecularMonitorMusNeuronsPathway interactionsPatientsPeptidesPhysiologicalPhysiological ProcessesPituitary GlandPlasmaPlayPositioning AttributePost-Translational Protein ProcessingPost-Translational RegulationProprotein ConvertasesProteolytic ProcessingRNARadioimmunoassayReceptor SignalingRegulationReportingRoleSignal PathwaySiteStagingStaining methodStainsSurgical ManagementTestingTherapeuticThyroid GlandTimeTumor Cell LineTumor SuppressionTumor Suppressor GenesTumor Suppressor ProteinsTumor-DerivedTyrosineUnspecified or Sulfate Ion SulfatesVertebratescancer typecartilage developmentcell agecell typeliquid chromatography mass spectrometrymemberneoplastic cellpromoterpublic health relevanceresearch studyrestorationsecretory proteinsulfationsynthetic peptidetraffickingtumor
项目摘要
DESCRIPTION (provided by applicant): Glioblastoma is the most common type of primary malignant brain tumor in adults and one of the most aggressive cancers. Even though there have been recent advances in surgical management of this type of cancer, the median survival time for these patients is approximately 14 months, most likely due to the loss of tumor suppressor expression within the tumor genome. Monitoring the level of certain molecules in either plasma or brain biopsies might provide us with information regarding the development/progression of a possible glioblastoma in early stage. Augurin, recently identified as a potential tumor suppressor, is a secretory molecule produced in the pituitary, brain, thyroid,
and esophagus. It is implicated in a wide array of physiological processes, from ACTH release to tumor suppression, and is well conserved among all vertebrates. Most interestingly, the expression of augurin is down-regulated by promoter hypermethylation in certain types of cancers, including glioblastoma. Secretory proteins are involved in diverse physiological functions, such as the regulation of metabolism, cell proliferation, differentiation, and cell deat; they require a number of posttranslational modifications during their trafficking through the secretory pathway in order to attain bioactive status. Without these posttranslational modifications, secretory proteins cannot exert their biological activities, resulting in deficiencis in physiological functions. However, information regarding the endogenous forms of proaugurin-derived peptides in various cell types has yet to be reported. The goal of this proposal is to understand the posttranslational modifications of proaugurin as a tumor suppressor. Our recent report has shown that two specific proaugurin-derived peptides are generated by the action of the specific proprotein convertase furin in vitro. Furthermore, we have found that proaugurin is sulfated during trafficking through the secretory pathway. Proliferation assays with a glioblastoma cell line demonstrated that only furin-cleaved proaugurin could suppress cell proliferation, suggesting that proteolytic cleavage is a posttranslational requirement for proaugurin to exhibit bioactivity. In addition, the predicted sulfation sites in augurin are highly
conserved among other species, supporting the idea that sulfation in augurin might contribute to the suppressive activity against tumor cell proliferation. In this proposal, we will determine the bioactive species of augurin that function to suppress tumor cell proliferation using its synthetic
peptides of proaugurin-derived peptides; perform mass spectrometry to determine the sulfation site(s) in augurin and clarify the importance of sulfation in augurin; determine the augurin levels
in normal and glial tumor-bearing mice using radioimmunoassay and immunohistochemical staining, to test the idea that lowered augurin expression may be a potential indicator of tumor-developing cells. These experiments will help to reveal molecular mechanisms involved in proaugurin maturation, and will provide clues to its biological importance as a tumor suppressor.
描述(申请人提供):胶质母细胞瘤是成人最常见的原发性恶性脑肿瘤,也是最具侵袭性的癌症之一。尽管最近在这种类型的癌症的手术治疗方面取得了进展,但这些患者的中位生存时间约为14个月,很可能是由于肿瘤基因组中肿瘤抑制基因表达的缺失。监测血浆或脑活检中某些分子的水平可能为我们提供早期胶质母细胞瘤发生/进展的信息。奥古林,最近被发现是一种潜在的肿瘤抑制因子,是一种分泌分子,在垂体、大脑、甲状腺、
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action.
- DOI:10.1016/j.bbr.2021.113234
- 发表时间:2021-05-21
- 期刊:
- 影响因子:2.7
- 作者:Ozawa A;Arakawa H
- 通讯作者:Arakawa H
Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents.
鉴定 5,6-二氢咪唑并[2,1-b]噻唑作为一类新型抗菌剂。
- DOI:10.1016/j.bmc.2016.09.027
- 发表时间:2016
- 期刊:
- 影响因子:3.5
- 作者:Li,Yangmei;Bionda,Nina;Fleeman,Renee;Wang,Hongjie;Ozawa,Akihiko;Houghten,RichardA;Shaw,Lindsey
- 通讯作者:Shaw,Lindsey
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Akihiko Ozawa其他文献
Akihiko Ozawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Akihiko Ozawa', 18)}}的其他基金
Dissecting active neural circuits regulating sensory and affective pain
剖析调节感觉和情感疼痛的活跃神经回路
- 批准号:
10206401 - 财政年份:2021
- 资助金额:
$ 21.41万 - 项目类别:
NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3
NPQ/Spexin 甘丙肽受体 3 的内源性配体
- 批准号:
9308906 - 财政年份:2016
- 资助金额:
$ 21.41万 - 项目类别:
NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3
NPQ/Spexin 甘丙肽受体 3 的内源性配体
- 批准号:
9185000 - 财政年份:2016
- 资助金额:
$ 21.41万 - 项目类别:
Posttranslational regulation of augurin, a new secretory tumor suppressor
新型分泌型肿瘤抑制因子 Augurin 的翻译后调控
- 批准号:
8510965 - 财政年份:2013
- 资助金额:
$ 21.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 21.41万 - 项目类别:
Research Grant














{{item.name}}会员




